LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein

Journal of Lipid Research

Volumn 46, Issue 1, 2005, Pages 115-122

  Asatryan, Liana ^a   Hamilton, Ryan T ^a   Isas, J Mario ^b   Hwang, Juliana ^a   Kayed, Rakez ^c   Sevanian, Alex ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

strand structures; Apolipoprotein B 100; Atherogenic low density lipoprotein; Lipid peroxidation; Nitrotyrosine; Oxidation; Protein structure; Secretory phospholipase A2; Unsaturated fatty acids

Indexed keywords

AMYLOID PROTEIN; ANTIBODY; APOLIPOPROTEIN B100; FATTY ACID; LOW DENSITY LIPOPROTEIN; OLIGOMER; PHOSPHOLIPASE A2; PHOSPHOLIPID; SNAKE VENOM;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROPHORETIC MOBILITY; HUMAN; LIPID HYDROLYSIS; LIPID PEROXIDATION; NITRATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; COBRA VENOMS; ELECTROPHORESIS; ELECTROSTATICS; FATTY ACIDS, UNSATURATED; HUMANS; HYDROLYSIS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PEROXYNITROUS ACID; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PROTEIN CONFORMATION; PROTEIN DENATURATION;

EID: 11244321987     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400306-JLR200     Document Type: Article

References (39)

1. - is a lipid hydroperoxide-enriched circulating lipoprotein. J. Lipid Res. 38: 419-428.
2. Sevanian, A., L. Asatryan, and O. Ziouzenkova. 1999. Low density lipoprotein (LDL) modification: basic concepts and relationship to atherosclerosis. Blood Purif. 17: 66-78.
3. Sanchez-Quesada, J. L., C. Otal-Entraigas, M. Franco, O. Jorba, F. Gonzalez-Sastre, F. Blanco-Vaca, and J. Ordonez-Llanos. 1999. Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia. Am. J. Cardiol. 84: 655-659.
4. Sanchez-Quesada, J. L., A. Perez, A. Caixas, J. Ordonez-Llanos, G. Carreras, A. Payes, F. Gonzalez-Sastre, and A. de Leiva. 1996. Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control. Diabetologia. 39: 1469-1476.
5. -) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation. Acta Diabetol. 35: 161-164.
6. - during the ex-vivo blood circulation. J. Biol. Chem. 274: 18916-18924.
7. Sanchez-Quesada, J. L., O. Jorba, A. Payes, C. Otal, R. Serra-Grima, F. Gonzalez-Sastre, and J. Ordonez-Llanos. 1998. Ascorbic acid inhibits the increase in low-density lipoprotein (LDL) susceptibility to oxidation and the proportion of electronegative LDL induced by intense aerobic exercise. Coron. Artery Dis. 9: 249-255.
8. Benitez, S., J. L. Sanchez-Quesada, L. Lucero, R. Arcelus, V. Ribas, O. Jorba, A. Castellvi, E. Alonso, F. Blanco-Vaca, and J. Ordonez-Llanos. 2002. Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids. Atherosclerosis. 160: 223-232.
9. Ursini, F., and A. Sevanian. 2002. Postprandial oxidative stress. Biol. Chem. 383: 599-605.
10. Sevanian, A., J. Hwang, H. N. Hodis, G. Cazzolato, P. Avogaro, and G. Bittolo-Bon. 1996. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations. Arterioscler. Thromb. 16: 784-793.
11. Parasassi, T., G. Bittolo-Bon, R. Brunelli, G. Cazzolato, E. K. Krasnowska, G. Mei, A. Sevanian, and F. Ursini. 2001. Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL(-). Free Radic. Biol. Med. 31: 82-89.
12. -, a potentially atherogenic low density lipoprotein subspecies. FEBS Lett. 499: 69-72.
13. Kuhn, H., J. Belkner, H. Suzuki, and S. Yamamoto. 1994. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J. Lipid Res. 35: 1749-1759.
14. Pentikainen, M. O., R. Oksjoki, K. Oorni, and P. T. Kovanen. 2002. Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more. Arterioscler. Thromb. Vasc. Biol. 22: 211-217.
15. Hwang, J., J. Wang, P. Morazzoni, H. N. Hodis, and A. Sevanian. 2003. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. Free Radic. Biol. Med. 34: 1271-1282.
16. Hwang, J., M. H. Ing, A. Salazar, B. Lassegue, K. Griendling, M. Navab, A. Sevanian, and T. K. Hsiai. 2003. Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ. Res. 93: 1225-1232.
17. 2 and small, dense low-density lipoprotein. Curr. Opin. Lipidol. 11: 465-471.
18. Jaross, W., R. Eckey, and M. Menschikowski. 2002. Biological effects of secretory phospholipase A(2) group IIA on lipoproteins and in atherogenesis. Eur. J. Clin. Invest. 32: 383-393.
19. 2 in human atherosclerotic plaques. Atherosclerosis. 118: 173-181.
20. 2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 17: 300-309.
21. 2 expression in human aortic tissue in dependence on the degree of atherosclerosis. Atherosclerosis. 144: 73-78.
22. 2. A spin-label study. Biochim. Biophys. Acta. 1300: 103-113.
23. Sartipy, P., G. Camejo, L. Svensson, and E. Hurt-Camejo. 1999. Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans. J. Biol. Chem. 274: 25913-25920.
24. 2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans. J. Biol. Chem. 273: 29127-29134.
25. 2. Atherosclerosis. 132: 165-176.
26. Kayed, R., E. Head, J. L. Thompson, T. M. McIntire, S. C. Milton, C. W. Cotman, and C. G. Glabe. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300: 486-489.
27. -). J. Lipid Res. 35: 669-677.
28. Auerbach, B. J., J. S. Kiely, and J. A. Cornicelli. 1992. A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Anal. Biochem. 201: 375-380.
29. Quehenberger, O., G. Jurgens, S. Zadravec, and H. Esterbauer. 1988. Oxidation of human low density lipoprotein initiated by copper (II) chloride. Basic Life Sci. 49: 387-390.
30. Ursini, F., K. J. Davies, M. Maiorino, T. Parasassi, and A. Sevanian. 2002. Atherosclerosis: another protein misfolding disease? Trends Mol. Med. 8: 370-374.
31. Oorni, K., M. O. Pentikainen, M. Ala-Korpela, and P. T. Kovanen. 2000. Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. J. Lipid Res. 41: 1703-1714.
32. 2 is linked to macrophage foam cell formation. J. Biol. Chem. 277: 29116-29124.
33. Jessup, W., and L. Kritharides. 2000. Metabolism of oxidized LDL by macrophages. Curr. Opin. Lipidol. 11: 473-481.
34. Segrest, J. P., M. K. Jones, V. K. Mishra, G. M. Anantharamaiah, and D. W. Garber. 1994. apoB-100 has a pentapartite structure composed of three amphipathic alpha-helical domains alternating with two amphipathic beta-strand domains. Detection by the computer program LOCATE. Arterioscler. Thromb. 14: 1674-1685.
35. Rubbo, H., R. Radi, M. Trujillo, R. Telleri, B. Kalyanaraman, S. Barnes, M. Kirk, and B. A. Freeman. 1994. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269: 26066-26075.
36. Neuzil, J., J. M. Upston, P. K. Witting, K. F. Scott, and R. Stocker. 1998. Secretory phospholipase A2 and lipoprotein lipase enhance 15-lipoxygenase-induced enzymic and nonenzymic lipid peroxidation in low-density lipoproteins. Biochemistry. 37: 9203-9210.
37. Viens, L., A. Athias, G. Lizard, G. Simard, S. Gueldry, S. Braschi, P. Gambert, C. Lallemant, and L. Lagrost. 1996. Effect of lipid transfer activity and lipolysis on low density lipoprotein (LDL) oxidizability: evidence for lipolysis-generated non-esterified fatty acids as inhibitors of LDL oxidation. J. Lipid Res. 37: 2179-2192.
38. Skoglund-Andersson, C., F. Karpe, M. L. Hellenius, J. Regnstrom, A. Hamsten, and P. Tornvall. 2003. In vitro and in vivo lipolysis of plasma triglycerides increases the resistance to oxidative modification of low-density lipoproteins. Eur. J. Clin. Invest. 33: 51-57.
39. Prassl, R., B. Schuster, P. Laggner, C. Flamant, F. Nigon, and M. J. Chapman. 1998. Thermal stability of apolipoprotein B100 in low-density lipoprotein is disrupted at early stages of oxidation while neutral lipid core organization is conserved. Biochemistry. 37: 938-944.